1. Home
  2. NRIX vs BBSI Comparison

NRIX vs BBSI Comparison

Compare NRIX & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRIX
  • BBSI
  • Stock Information
  • Founded
  • NRIX 2009
  • BBSI 1965
  • Country
  • NRIX United States
  • BBSI United States
  • Employees
  • NRIX N/A
  • BBSI N/A
  • Industry
  • NRIX Biotechnology: Pharmaceutical Preparations
  • BBSI Professional Services
  • Sector
  • NRIX Health Care
  • BBSI Consumer Discretionary
  • Exchange
  • NRIX Nasdaq
  • BBSI Nasdaq
  • Market Cap
  • NRIX 1.1B
  • BBSI 1.1B
  • IPO Year
  • NRIX 2020
  • BBSI 1993
  • Fundamental
  • Price
  • NRIX $12.06
  • BBSI $41.20
  • Analyst Decision
  • NRIX Strong Buy
  • BBSI Buy
  • Analyst Count
  • NRIX 17
  • BBSI 3
  • Target Price
  • NRIX $30.71
  • BBSI $41.67
  • AVG Volume (30 Days)
  • NRIX 739.8K
  • BBSI 154.3K
  • Earning Date
  • NRIX 07-10-2025
  • BBSI 05-07-2025
  • Dividend Yield
  • NRIX N/A
  • BBSI 0.77%
  • EPS Growth
  • NRIX N/A
  • BBSI 6.65
  • EPS
  • NRIX N/A
  • BBSI 1.96
  • Revenue
  • NRIX $56,417,000.00
  • BBSI $1,171,315,000.00
  • Revenue This Year
  • NRIX $15.43
  • BBSI $9.91
  • Revenue Next Year
  • NRIX N/A
  • BBSI $7.39
  • P/E Ratio
  • NRIX N/A
  • BBSI $21.09
  • Revenue Growth
  • NRIX N/A
  • BBSI 8.41
  • 52 Week Low
  • NRIX $8.18
  • BBSI $31.23
  • 52 Week High
  • NRIX $29.56
  • BBSI $44.97
  • Technical
  • Relative Strength Index (RSI)
  • NRIX 66.26
  • BBSI 48.65
  • Support Level
  • NRIX $9.67
  • BBSI $40.50
  • Resistance Level
  • NRIX $10.79
  • BBSI $42.40
  • Average True Range (ATR)
  • NRIX 0.60
  • BBSI 0.85
  • MACD
  • NRIX 0.27
  • BBSI -0.10
  • Stochastic Oscillator
  • NRIX 84.13
  • BBSI 30.89

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

Share on Social Networks: